FDA Clears Ultherapy PRIME for Skin Laxity on the Knees
The FDA has cleared Merz Aesthetics’ Ultherapy PRIME to improve the appearance of skin laxity on the knees, expanding the device’s body indications.
The FDA has cleared Merz Aesthetics’ Ultherapy PRIME to improve the appearance of skin laxity on the knees, expanding the device’s body indications.
Operating with a 16W diode, the platform expands full-body skin revitalization settings across mJOULE and JOULE X systems.